(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs - 25 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- 3Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- 4Quantum Computing’s Next Major Breakthroughs Could Come From Australia
- 5Find the Standards of Viable Refereeing: Settling Debates with Strategy
- Figure out How to Establish a long term connection with Your Handshake
- Nations for Youngsters to Visit
- NASA to bring astronauts home from space station early due to a medical issue
- The Most Well known Online Entertainment Forces to be reckoned with of 2023
- Find Successful Magnificence Items for Sparkling Skin
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
- Incredible Travel Objections for Craftsmanship Darlings to Visit
- Rick Steves Doesn't Want You Overlooking This Food Spot While In France
- Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.'
